A population analysis of VEGF transgene expression and secretion

Biotechnology and Bioengineering

Volumn 101, Issue 5, 2008, Pages 1083-1093

  Karoubi, Golnaz ^a,b   Stewart, Duncan J ^b   Courtman, David W ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiogenesis; Cell encapsulation; Flow cytometry; Gene expression; Gene therapy; Hydrogel

Indexed keywords

BIOACTIVITY; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLS; COLLOIDS; ENDOTHELIAL CELLS; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ENGINEERING; MICROSCOPIC EXAMINATION; NUCLEIC ACIDS; PEPTIDES; POPULATION STATISTICS;

ANGIOGENESIS; CELL ENCAPSULATION; CELL POPULATIONS; CELL SECRETIONS; CELL-BASED; COPY NUMBERS; GENE THERAPIES; GENE THERAPY; GROWTH FACTORS; MICROENVIRONMENT; PLASMID TRANSFECTIONS; POPULATION ANALYSIS; PROTEIN DELIVERIES; PROTEIN SECRETIONS; SINGLE CELLS; TOTAL PROTEINS; TRANSFECTED CELLS; TRANSGENE EXPRESSIONS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

CYTOLOGY;

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; NONHUMAN; PLASMID; PROTEIN SECRETION; RAT; REPRODUCIBILITY; TECHNIQUE; TRANSGENE;

ANIMALS; CELLS, CULTURED; CULTURE TECHNIQUES; ELECTROPORATION; FIBROBLASTS; GENE EXPRESSION; GENE THERAPY; PLASMIDS; RATS; TRANSFECTION; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56449114711     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21993     Document Type: Article

References (38)

1. Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J, Symes JF, Isner JM. 1996. Accelerated restitution of endothelial integrity and endothelium-dependent function after ph VEGF165 gene transfer. Circulation 94:3291-3220.
2. Bally MB, Harvie P, Wong F, Kong S, Wasan E, Reimer DL. 1999. Biological barriers to cellular delivery of lipid-based DNA carriers. Adv Drug Delivery Rev 38:291-315.
3. Banfi A, von Degenfeld G, Blau H. 2005. Critical role of microenvironmental factors in angiogenesis. Curr Atherosclerosis Rep 7:227-234.
4. Batard P, Jordan M, Wurm F. 2001. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene 270:61-68.
5. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. 1995. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 21:314-325.
6. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. 1995. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91:2802-2809.
7. Brown MD, Schatzlein A, Uchegbu IF. 1991. Gene delivery with synthetic (non viral) carriers. Int J Pharm 229:1-21.
8. Campbell A, Zhao Y, Sandhu R, Stewart D. 2001. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrataline-induced pulmonary hypertension. Circulation 104:2242-2248.
9. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. 2001. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011.
10. Ferrara N. 1999. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527-543.
11. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocrine Rev 18:4-25.
12. Fiorina P, Secchi A. 2007. Pancreatic islet cell transplant for treatment of diabetes. Encrinol Metab Clin N Am 36:999-1013.
13. Genovesse J, Cortes-Morichetti N, Chachques E, Frati G, Patel A, Chachques JC. 2007. Cell-based approaches for myocardial regeneration and artificial myocardium. Curr Stem Cell Res Ther 2:121-127.
14. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N, Yoon K, Rossant J, Iruela-Arispe ML, Kalen M, Herhardt H, Betsholtz C. 2007. D114 signalling through Notch 1 regulates formation of Tipp cells during angiogenesis. Nature 445:776-780.
15. Hoeben A, Landuyt B, Highley MS, Wildiers H, van Oosterom AT, De Bruijn EA. 2004. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549-580.
16. Hogan A, Pileggi A, Ricordi C. 2008. Transplantation: Current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. Front Biosci 13:1192-1205.
17. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. 1996. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370-374.
18. Kim K-J, Kim HE, Lee KH, Han W, Yi MJ, Jeong J, Oh BH. 2004. Two-promoter vector is highly efficient for overproduciton of protein complexes. Protein Sci 13:1698-1703.
19. Kofidis T, Nolte D, Simon AR, Metzakis A, Balsam L, Robbins R, Haverich A. 2002. Restoration of blood flow and evaluation of corresponding angiogenic events by scanning electron microscopy after a single dose of VEGF in a model of peripheral vascular disease. Angiogenesis 5:87-92.
20. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. 2000. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1:376-382.
21. Murphy WL, Peters MC, Kohn DH, Mooney DJ. 2000. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-coglycolide) scaffolds for tissue engineering. Biomaterials 21:2521-2527.
22. Nomi M, Atala A, De Coppi P, Soker S. 2002. Principals of neovascularization for tissue engineering. Mol Aspects Med 23:463-483.
23. Ott HC, McCue J, Taylor DA. 2005. Cell based cardiovascular repair - The hurdles and the opportunities. Basic Res Cardiol 100:504-517.
24. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM. 2004. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113:516-527.
25. Patil SD, Papadmitrakopoulos F, Burgess DJ. 2007. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 117:68-79.
26. Richardson TP, Peters MC, Ennett AB, Mooney DJ. 2001. Polymeric system for dual growth factor delivery. Nat Biotech 19:1029-1034.
27. Rubanyi GM. 2001. The future of human gene therapy. Mol Aspects Med 22:113-142.
28. Rucker P, Torti F, Torti S. 1997. Recombinant ferritin: Modulation of subunit stoichiometry in bacterial expression systems. Protein Eng 10:967-973.
29. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT. 2002. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16:2684-2698.
30. Soker S, Fidder H, Neufeld G, Klagsbrun M. 1996. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bid VEGF165 via its exon 7-encoded domain. J Biol Chem 271:5761-5767.
31. Stewart DJ, Zhao Y, Courtman DW. 2004. Cell therapy of pulmonary hypertension: What is the true potential of endothelial progenitor cells? Circulation 109:e172-e173.
32. Tachibana R, Harashima H, Ide N, Ukitsu S, Ohta Y, Suzuki N, Kikushi H, Shinohara Y, Kiwada H. 2002. Quantitative analysis and correlation between number of nuclear plasmids and gene expression activity after transfection with cationic liposomes. Pharm Res 19:377-381.
33. Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Syme J, Ferrara N, Isner JM. 1996. Gene transfer of naked DNA encoding for three isoforms of vascular enodthelial growth factor stimulates collateral development in vivo. Lab Invest 75:487-501.
34. Tseng W-C, Haselton F, Giorgio T. 1997. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 272:25641-25647.
35. Yancopoulos GD, Klagsbrun M, Folkman J. 1998. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border. Cell 93:661-664.
36. Young J, Dean D. 2000. Nonviral gene transfer strategies for the vasculature. Microcirculation 9:35-50.
37. Young Y-S, Johnson IA, Park JS, Diaz L, Losordo DW. 2004. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 264:63-74.
38. Zhao YD, Courtman DW, Ng DS, Robb MJ, Deng YP, Trogadis J, Han RN, Stewart DJ. 2006. Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer. Am J Respir Cell Mol Biol 35:182-189.